Ligand Pharmaceuticals Incorporated Equity-NMS: LGND

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$109.7
Open :$108.91
Today's high :$109.82
Today's low :$106.43
52W low :$67.72
52W high :$129.9
1Y :51.89%
5Y :150.57%
EPS(TTM): :-0.22
Shares O/S :19.26 M
Market cap :2.07 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Ligand Pharmaceuticals Incorporated $107.59 -2.88% - 2.07B

Frequently Asked Questions

What is the share price of Ligand Pharmaceuticals Incorporated today?

Ligand Pharmaceuticals Incorporated (LGND) share price as of April 1, 2025, is $109.67. If you are investing from India, you can always check the valuation in the INR before investing.

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. It does this by financing, licensing its technologies or both. It operates two infrastructure-light royalty-generating IP platform technologies. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled FDA-approved products, including Gilead’s Veklury, Amgen’s Kyprolis, Baxter’s Nexterone, and Acrotech Biopharma’s Evomela. Its NITRICIL platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a range of indications. Its technologies also include HepDirect, LTP and BEPro Technology Platform, and Pelican Expression Technology. It has multiple alliances, licenses and other business relationships with various pharmaceutical companies.